In the BioHarmony Drug Report Database

"Preview" Icon

Dinoprostone

Cervidil, Prepidil, Prostin E (dinoprostone) is a small molecule pharmaceutical. Dinoprostone was first approved as Cervidil on 1982-01-01. It is used to treat fetal death, gestational trophoblastic disease, and uterine neoplasms in the USA. It is known to target prostaglandin E2 receptor EP4 subtype, solute carrier organic anion transporter family member 2A1, solute carrier organic anion transporter family member 3A1, prostaglandin E2 receptor EP2 subtype, prostaglandin E2 receptor EP3 subtype, and prostaglandin E2 receptor EP1 subtype.

 

Trade Name

 

Cervidil, Prepidil, Prostin E
 

Common Name

 

dinoprostone
 

ChEMBL ID

 

CHEMBL548
 

Indication

 

fetal death, gestational trophoblastic disease, uterine neoplasms
 

Drug Class

 

Prostaglandins

Image (chem structure or protein)

Dinoprostone structure rendering